R. Damade

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

N. Costedoat‐Chalumeau, Lionel Galicier, O. Aumaître et al. · Annals of the Rheumatic Diseases · 2012 · 206 citations

Medicine, Pharmacology, Pharmacotherapy +15

Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies

Christian Pagnoux, Véronique Le Guern, François Goffinet et al. · Lara D. Veeken · 2010 · 69 citations · Full text

Medicine, Obstetrics, Pathology +10

Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

Éric Toussirot, Hubert Marotte, Denis Mulleman et al. · Arthritis Research & Therapy · 2020 · 50 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case–control study with hydroxychloroquine blood-level analysis

Tiphaine Lenfant, Gaëlle Leroux, Elodie Bousquet et al. · Lara D. Veeken · 2020 · 49 citations · Full text

Health Professions, Ophthalmology, Pharmacotherapy +13